Genpact Limited reported $5.25B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.25B (to Q2 2026). Net income: $583M, trailing twelve months to Q2 2026. Free cash flow: $572M, trailing twelve months to Q2 2026. Operating margin: 15%, trailing twelve months to Q2 2026.

GGenpact Limited

Technology

$34.40-15% 1Y

$34.40

$27.6752 weeks$47.98

G as reported

Genpact Limited reported $5.25B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed.

$5.25B

Revenue, trailing twelve months · to Q2 2026 · +6.5% against the twelve months before

Net income: $583M
Net income · +8.2% year on year · trailing twelve months to Q2 2026
Free cash flow: $572M
Free cash flow · +1.1% year on year · trailing twelve months to Q2 2026
Operating margin: 15%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for G, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.25B	+6.5%	Q2 2026
Net income	$583M	+8.2%	Q2 2026
EPS	$3.37	+12%	Q2 2026
Gross margin	36%	n/a	Q2 2026
Operating margin	15%	n/a	Q2 2026
Net margin	11%	n/a	Q2 2026
ROE	22%	n/a	Q2 2026
ROA	10%	n/a	Q2 2026
ROIC	20%	n/a	Q2 2026
Free cash flow	$572M	+1.1%	Q2 2026
P/E	10.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.